November 02, 2010
Financial News, November 2010
LifeVantage Corporation (LFVN—OTC BB) reported net revenues of $11.5 million and a net loss of $11 million, or 19 cents per share, for its year ended June 30, 2010. For its year ended June 30, 2009, the company recorded net revenues of $4.1 million and a net loss of $9.1 million, or 23 cents per share.
LifeVantage Corporation is a publicly traded, science-based, nutraceutical company dedicated to helping people reach their health and wellness goals. Founded in 2003 and based in San Diego, LifeVantage develops products, including Protandim®, intended to deliver significant health benefits to consumers.
Blyth Inc. (BTH—NYSE) reported that net sales for the second quarter ended July 31, 2010, declined approximately 9 percent to $180.6 million from $199.4 million for the prior year period. Sales declined 8 percent on a local currency basis. International sales represented 39 percent of total sales in the second quarter both this year and last year.
In the direct selling segment, second quarter net sales declined 11 percent, which translated into a 9 percent decline on a local currency basis, to $110.2 million versus $123.3 million for the same period last year. PartyLite’s U.S. sales declined 20 percent, and active independent sales consultants now total more than 16,000 in the United States, versus more than 18,000 in last year’s second quarter. In PartyLite Canada, sales declined 15 percent in U.S. dollars during the quarter, which translated into a decline of 22 percent in local currency, with active independent sales consultants totaling more than 4,000 this year and last year.
PartyLite Europe’s sales declined 12 percent in U.S. dollars during the quarter, which translated into a decline of 6 percent in local currency. PartyLite’s European active independent sales consultants totaled more than 29,000 in this year’s second quarter versus over 28,000 in last year’s second quarter.
Blyth Inc., based in Greenwich, Conn., is a Home Expressions company that markets an extensive array of home-fragrance products, decorative accessories, seasonal decorations and household convenience items. The company sells its products through multiple channels of distribution, including the home party plan method of direct selling, as well as through the catalog, Internet and wholesale channels.
Immunotec Inc. (IMM—TSX VENTURE) reported financial results for the third quarter of fiscal year 2011. Revenues after nine months totaled $30.3 million, compared to $34.0 million for the corresponding period last fiscal year. After nine months and despite absorbing this new acquisition in Mexico, the company was able to maintain an adjusted EBITDA(1) of $1.4 million, or 5 percent of revenues, compared to a loss $148 thousand for Fiscal 2009.
Immunotec is engaged primarily in the development and marketing of dietary supplements, food, vitamins and personal care and natural health products. Immunotec’s products are distributed and sold in Canada and the United States through a network marketing system, and in other countries under distributorship agreements.
Direct Selling News has accumulated this information from public sources, including press releases and SEC filings. The information is presumed accurate and reliable. However, it is not an endorsement of any investment opportunity. Proper and considerable due diligence should be completed before making any investment.